ALTERED ALVEOLAR SURFACTANT IS AN EARLY MARKER OF ACUTE LUNG INJURY IN SEPTIC ADULT SHEEP

被引:54
作者
LEWIS, JF
VELDHUIZEN, R
POSSMAYER, F
SIBBALD, W
WHITSETT, J
QANBAR, R
MCCAIG, L
机构
[1] UNIV WESTERN ONTARIO HOSP,DEPT OBSTET & GYNECOL,LONDON N6A 5A5,ON,CANADA
[2] VICTORIA HOSP,CTR CRIT CARE TRAUMA,DEPT MED,LONDON N6A 4G5,ON,CANADA
[3] UNIV CINCINNATI,COLL MED,DEPT PEDIAT,CINCINNATI,OH 45267
关键词
D O I
10.1164/ajrccm.150.1.8025737
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The purpose of this study was to characterize changes in the endogenous surfactant system in adult sheep rendered septic via cecal ligation and perforation (CLP). Forty-eight hours after CLP, septic animals had significant increases in mean pulmonary artery pressure (PAP) (p < 0.01), cardiac index (Cl) (p < 0.01), and arterial lactate (p < 0.05) values compared with their respective baseline values, while the same measurements in a sham-operated control group did not change significantly. The changes in the septic group were associated with significantly lower Pa-O2 (p < 0.05) and alveolar to arterial (A-a) oxygen gradient values (P < 0.01) at 48 h compared with baseline measurements. No changes in oxygenation occurred within the sham-operated group. Surfactant phospholipid (PL) composition and surface activity measurements of isolated alveolar surfactant aggregate forms were similar for the two groups at 48 h. However, the ratio of poorly functioning small aggregate forms (SA) to superior functioning large aggregates (LA) was significantly increased in the septic versus the sham-operated animals (p < 0.01). This was associated with significantly decreased surfactant protein A (SP-A), B (SP-B), and C (SP-C) levels in septic versus sham-operated animals (p < 0.05). We conclude that sepsis-associated lung injury resulted in altered alveolar surfactant aggregate forms. These changes, together with altered surfactant protein levels, may represent a very sensitive marker of acute lung injury in high-risk patients. Furthermore, these findings suggest that exogenous surfactant given at an early stage of lung injury may mitigate progressive lung dysfunction.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 38 条
[1]  
ASHBAUGH DG, 1967, LANCET, V2, P319
[2]  
BERNARD G R, 1989, American Review of Respiratory Disease, V139, pA221
[3]   HIGH-DOSE CORTICOSTEROIDS IN PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERNARD, GR ;
LUCE, JM ;
SPRUNG, CL ;
RINALDO, JE ;
TATE, RM ;
SIBBALD, WJ ;
KARIMAN, K ;
HIGGINS, S ;
BRADLEY, R ;
METZ, CA ;
HARRIS, TR ;
BRIGHAM, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (25) :1565-1570
[4]  
COCHRANE CG, 1983, AM REV RESPIR DIS, V127, P25
[5]   PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A ENHANCES THE SURFACE-ACTIVITY OF LIPID EXTRACT SURFACTANT AND REVERSES INHIBITION BY BLOOD PROTEINS INVITRO [J].
COCKSHUTT, AM ;
WEITZ, J ;
POSSMAYER, F .
BIOCHEMISTRY, 1990, 29 (36) :8424-8429
[6]  
CRAIG I, 1987, AM J PATHOL, V128, P241
[7]   RAPID SENSITIVE METHOD FOR DETERMINING PHOSPHOLIPID PHOSPHORUS INVOLVING DIGESTION WITH MAGNESIUM-NITRATE [J].
DUCKCHONG, CG .
LIPIDS, 1979, 14 (05) :492-497
[8]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[9]   SURFACTANT CHEMICAL-COMPOSITION AND BIOPHYSICAL ACTIVITY IN ACUTE RESPIRATORY-DISTRESS SYNDROME [J].
GREGORY, TJ ;
LONGMORE, WJ ;
MOXLEY, MA ;
WHITSETT, JA ;
REED, CR ;
FOWLER, AA ;
HUDSON, LD ;
MAUNDER, RJ ;
CRIM, C ;
HYERS, TM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1976-1981
[10]   SERINE PROTEINASE REQUIREMENT FOR THE EXTRACELLULAR METABOLISM OF PULMONARY SURFACTANT [J].
GROSS, NJ ;
SCHULTZ, RM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (02) :222-230